Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 18/20 | 0.57 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.47 |
| ▸ | CTSL | P07711 | 1/20 | 0.46 |
| ▸ | CTSB | P07858 | 1/20 | 0.46 |
| ▸ | CTSS | P25774 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6296540 | 1.00 | CTSK (0.57) | CTSKCA1CA2CA7CTSL | |
| SCHEMBL6296542 | 1.00 | CTSK (0.57) | CTSKCA1CA2CA7CTSL | |
| SCHEMBL7260242 | 1.00 | CTSK (0.57) | CTSKCA1CA2CA7CTSL | |
| SCHEMBL16564868 | 0.84 | CTSK (0.53) | CTSKCA1CA2CA7CTSL | |
| SCHEMBL7433177 | 0.84 | CTSK (0.53) | CTSKCA1CA2CA7CTSL | |
| SCHEMBL6786634 | 0.84 | CTSK (0.53) | CTSKCA1CA2CA7CTSL | |
| SCHEMBL6829984 | 0.82 | CA1 (0.51) | CTSKCA1CA2CA7CTSL | |
| SCHEMBL9644705 | 0.82 | CTSK (0.62) | CTSKCA1CA2CA7CTSL | |
| SCHEMBL739719 | 0.82 | CTSK (0.62) | CTSKCA1CA2CA7CTSL | |
| SCHEMBL1781832 | 0.82 | CTSK (0.62) | CTSKCA1CA2CA7CTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12570675-B2 | Boronic acid compounds | LG CHEM, LTD. (KR) | 2026-03-10 | — | — | US | disclosed |
| US-20240101579-A1 | BORONIC ACID COMPOUNDS | LG CHEM, LTD. (KR) | 2024-03-28 | — | — | US | disclosed |
| EP-4242213-A1 | BORONIC ACID COMPOUND | Lg Chem, Ltd. (KR) | 2023-09-13 | — | — | EP | disclosed |
| CN-116568310-A | Boric acid compounds | 株式会社LG化学 | 2023-08-08 | — | — | CN | disclosed |
| WO-2022123530-A1 | BORONIC ACID COMPOUND | 주식회사 엘지화학 | 2022-06-16 | — | — | WO | disclosed |
| WO-2003018577-A1 | ANTIVIRAL NUCLEOSIDE DERIVATIVES AND PROCESS FOR PREPARING THE SAME | POSTECH FOUNDATION (KR) | 2003-03-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570675-B2 | Boronic acid compounds | PSMB6, PSMB3, PSMB2 | CTSK 1682/4885CA1 477/4885CA2 309/4885 |
| US-20240101579-A1 | BORONIC ACID COMPOUNDS | PSMB11, PSMB1, BACH1 | CTSK 2553/4885CA1 1530/4885CA2 1672/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.